Search

Search Constraints

You searched for: Author/Creator Ledermann, Jonathan

Search Results

1. Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. Issue 11 (27th November 2018)

2. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Issue 9 (30th October 2018)

3. Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. (October 2019)

4. ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Issue 3 (December 2015)

5. European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015. Issue 7 (1st September 2015)

7. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary. (1st November 2014)

8. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the Cervix. (1st November 2014)

9. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors). (1st November 2014)

10. 596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36). (14th December 2020)